These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 23305243)
1. Binding kinetics and affinities of heterodimeric versus homodimeric HIV-1 reverse transcriptase on DNA-DNA substrates at the single-molecule level. Marko RA; Liu HW; Ablenas CJ; Ehteshami M; Götte M; Cosa G J Phys Chem B; 2013 Apr; 117(16):4560-7. PubMed ID: 23305243 [TBL] [Abstract][Full Text] [Related]
2. HIV-1 reverse transcriptase interaction with model RNA-DNA duplexes. Gorshkova II; Rausch JW; Le Grice SF; Crouch RJ Anal Biochem; 2001 Apr; 291(2):198-206. PubMed ID: 11401293 [TBL] [Abstract][Full Text] [Related]
3. p66/p51 and p51/p51 recombinant forms of reverse transcriptase from human immunodeficiency virus type 1--interactions with primer tRNA(Lys3), initiation of cDNA synthesis, and effect of inhibitors. Dufour E; El Dirani-Diab R; Boulmé F; Fournier M; Nevinsky G; Tarrago-Litvak L; Litvak S; Andreola ML Eur J Biochem; 1998 Jan; 251(1-2):487-95. PubMed ID: 9492322 [TBL] [Abstract][Full Text] [Related]
4. The p51 subunit of human immunodeficiency virus type 1 reverse transcriptase is essential in loading the p66 subunit on the template primer. Harris D; Lee R; Misra HS; Pandey PK; Pandey VN Biochemistry; 1998 Apr; 37(17):5903-8. PubMed ID: 9558323 [TBL] [Abstract][Full Text] [Related]
5. Analysis of the polymerization kinetics of homodimeric EIAV p51/51 reverse transcriptase implies the formation of a polymerase active site identical to heterodimeric EIAV p66/51 reverse transcriptase. Souquet M; Restle T; Krebs R; Le Grice SF; Goody RS; Wöhrl BM Biochemistry; 1998 Sep; 37(35):12144-52. PubMed ID: 9724526 [TBL] [Abstract][Full Text] [Related]
7. Proteolytic processing of an HIV-1 pol polyprotein precursor: insights into the mechanism of reverse transcriptase p66/p51 heterodimer formation. Sluis-Cremer N; Arion D; Abram ME; Parniak MA Int J Biochem Cell Biol; 2004 Sep; 36(9):1836-47. PubMed ID: 15183348 [TBL] [Abstract][Full Text] [Related]
8. Relationship between enzyme activity and dimeric structure of recombinant HIV-1 reverse transcriptase. Tachedjian G; Radzio J; Sluis-Cremer N Proteins; 2005 Jul; 60(1):5-13. PubMed ID: 15852304 [TBL] [Abstract][Full Text] [Related]
9. Subunit-specific analysis of the human immunodeficiency virus type 1 reverse transcriptase in vivo. Mulky A; Sarafianos SG; Arnold E; Wu X; Kappes JC J Virol; 2004 Jul; 78(13):7089-96. PubMed ID: 15194785 [TBL] [Abstract][Full Text] [Related]
10. Kinetics of association and dissociation of HIV-1 reverse transcriptase subunits. Venezia CF; Meany BJ; Braz VA; Barkley MD Biochemistry; 2009 Sep; 48(38):9084-93. PubMed ID: 19715314 [TBL] [Abstract][Full Text] [Related]
11. Binding of RNA template to a complex of HIV-1 reverse transcriptase/primer/template. Canard B; Sarfati R; Richardson CC Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11279-84. PubMed ID: 9326600 [TBL] [Abstract][Full Text] [Related]
12. Buried surface analysis of HIV-1 reverse transcriptase p66/p51 heterodimer and its interaction with dsDNA template/primer. Ding J; Jacobo-Molina A; Tantillo C; Lu X; Nanni RG; Arnold E J Mol Recognit; 1994 Jun; 7(2):157-61. PubMed ID: 7530020 [TBL] [Abstract][Full Text] [Related]
13. Effects of efavirenz binding on the subunit equilibria of HIV-1 reverse transcriptase. Venezia CF; Howard KJ; Ignatov ME; Holladay LA; Barkley MD Biochemistry; 2006 Mar; 45(9):2779-89. PubMed ID: 16503633 [TBL] [Abstract][Full Text] [Related]
14. The HIV-1 p66 homodimeric RT exhibits different conformations in the binding-competent and -incompetent NNRTI site. Sharaf NG; Xi Z; Ishima R; Gronenborn AM Proteins; 2017 Dec; 85(12):2191-2197. PubMed ID: 28905420 [TBL] [Abstract][Full Text] [Related]
15. Feline immunodeficiency virus reverse transcriptase: expression, functional characterization, and reconstitution of the 66- and 51-kilodalton subunits. Amacker M; Hottiger M; Hübscher U J Virol; 1995 Oct; 69(10):6273-9. PubMed ID: 7545246 [TBL] [Abstract][Full Text] [Related]
16. Spatial domain organization in the HIV-1 reverse transcriptase p66 homodimer precursor probed by double electron-electron resonance EPR. Schmidt T; Schwieters CD; Clore GM Proc Natl Acad Sci U S A; 2019 Sep; 116(36):17809-17816. PubMed ID: 31383767 [TBL] [Abstract][Full Text] [Related]
17. The N137 and P140 amino acids in the p51 and the P95 amino acid in the p66 subunit of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase are instrumental to maintain catalytic activity and to design new classes of anti-HIV-1 drugs. Auwerx J; Van Nieuwenhove J; Rodríguez-Barrios F; de Castro S; Velázquez S; Ceccherini-Silberstein F; De Clercq E; Camarasa MJ; Perno CF; Gago F; Balzarini J FEBS Lett; 2005 Apr; 579(11):2294-300. PubMed ID: 15848161 [TBL] [Abstract][Full Text] [Related]
18. The N348I mutation at the connection subdomain of HIV-1 reverse transcriptase decreases binding to nevirapine. Schuckmann MM; Marchand B; Hachiya A; Kodama EN; Kirby KA; Singh K; Sarafianos SG J Biol Chem; 2010 Dec; 285(49):38700-9. PubMed ID: 20876531 [TBL] [Abstract][Full Text] [Related]
19. Stabilization of human immunodeficiency virus type 1 reverse transcriptase by site-directed mutagenesis. Nishimura K; Shinomura M; Konishi A; Yasukawa K Biotechnol Lett; 2013 Dec; 35(12):2165-75. PubMed ID: 24078120 [TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships in HIV-1 reverse transcriptase revealed by radiation target analysis. Sluis-Cremer N; Kempner E; Parniak MA Protein Sci; 2003 Sep; 12(9):2081-6. PubMed ID: 12931006 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]